Bamco Inc. NY Purchases Shares of 3,500 Tenet Healthcare Corporation $THC

Bamco Inc. NY acquired a new position in Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,500 shares of the company’s stock, valued at approximately $711,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $35,000. Westside Investment Management Inc. lifted its holdings in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares in the last quarter. Trust Co. of Vermont purchased a new position in Tenet Healthcare during the third quarter valued at $41,000. Finally, Geneos Wealth Management Inc. increased its holdings in Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after acquiring an additional 89 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the sale, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 46,517 shares of company stock worth $10,943,111. Insiders own 0.81% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on THC shares. UBS Group increased their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Royal Bank Of Canada increased their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Finally, Guggenheim increased their target price on Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Stock Performance

NYSE THC opened at $219.58 on Tuesday. The company has a market cap of $19.09 billion, a P/E ratio of 14.18, a P/E/G ratio of 1.10 and a beta of 1.39. The business’s 50 day moving average price is $213.71 and its 200-day moving average price is $204.56. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $247.21. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the previous year, the firm earned $3.44 earnings per share. Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.